e-learning
resources
Berlin 2008
Monday, 06.10.2008
Epidemiology and clinical management of multidrug-resistant and extensively drug-resistant tuberculosis
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Rapid resistance detection of
Mycobacterium tuberculosis
to second-line drugs using the manual mycobacterium growth indicator tube (MGIT) system.
A. Martin, F. Varaine, A. Von Groll, K. Fissette, F. Portaels, J. C. Palomino (Antwerp, Belgium; Paris, France; Rio Grande, Brazil)
Source:
Annual Congress 2008 - Epidemiology and clinical management of multidrug-resistant and extensively drug-resistant tuberculosis
Session:
Epidemiology and clinical management of multidrug-resistant and extensively drug-resistant tuberculosis
Session type:
Thematic Poster Session
Number:
2534
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Martin, F. Varaine, A. Von Groll, K. Fissette, F. Portaels, J. C. Palomino (Antwerp, Belgium; Paris, France; Rio Grande, Brazil). Rapid resistance detection of
Mycobacterium tuberculosis
to second-line drugs using the manual mycobacterium growth indicator tube (MGIT) system.. Eur Respir J 2008; 32: Suppl. 52, 2534
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
Debate -Tuberculosis: Rolling out of new drugs without diagnostic capacities
Panel discussion on unprecedented progress in shortening treatment for TB: Evidence to date, and future possibilities
Related content which might interest you:
The results of drug susceptibility testing of mycobacterium tuberculosis to rifampicin by Xpert® MTB / Rif, BACTEC MGIT 960 as compared with the method of seeding on solid nutrient media
Source: International Congress 2016 – Microbiology: bronchoalveolar lavage (BAL) and PCR
Year: 2016
Determination of drug susceptibility of
Mycobacterium tuberculosis
through mycolic acid analysis with HPLC technique - comparison to the conventional methods
Source: Annual Congress 2005 - Management of tuberculosis pulmonary, extrapulmonary peculiarities
Year: 2005
Express diagnostics of mycobacterium tuberculosis (MBT) drug resistance at disseminated tuberculosis (DT)
Source: Annual Congress 2008 - Diagnosis of tuberculosis: problems and perspectives
Year: 2008
Detection of isoniazid or rifampin resistant
Mycobacterium tuberculosis
in patients with cavity and previously treated for tuberculosis - usefulness of rapid drug susceptibility test with sputum samples by reverse hybridization assay
Source: Annual Congress 2005 - Resistant and multidrug resistant tuberculosis
Year: 2005
Line probe assay (LiPA) based rapid detection of multiple drug resistent (MDR) mycobacterium tuberculosis (MTB)
Source: Annual Congress 2012 - Microbiological advances in the diagnosis of tuberculosis
Year: 2012
Xpert MTB/RIF assay for rapid detection of Mycobacterium tuberculosis and rifampicin resistance
Source: Annual Congress 2012 - Microbiological advances in the diagnosis of tuberculosis
Year: 2012
Evaluation of the microscopic observation drug susceptibility assay for the detection of first- and second-line drug susceptibility for Mycobacterium tuberculosis
Source: Eur Respir J , 49 (4) 1602215; DOI: 10.1183/13993003.02215-2016
Year: 2017
Evaluation of a line probe assay kit for direct and simultaneous detection of mycobacterium tuberculosis complex and its resistance to rifampin
Source: Annual Congress 2009 - Treatment of tuberculosis at times of emerging drug resistance
Year: 2009
Evaluation of a rapid bactriophage assay for the detection of
mycobacterium tuberculosis
Source: Annual Congress 2007 - Research perspectives: diagnosis and treatment of tuberculosis
Year: 2007
Microbiology of
Mycobacterium tuberculosis
and a new diagnostic test for TB
Source: Eur Respir Mon 2012; 58: 1-13
Year: 2012
Rapid genomic first- and second-line drug resistance prediction from clinical
Mycobacterium tuberculosis
specimens using Deeplex-MycTB
Source: Eur Respir J, 57 (1) 2001796; 10.1183/13993003.01796-2020
Year: 2021
Colorimetric assays for rapid drug susceptibility testing of
Mycobacterium tuberculosis
Source: Eur Respir J 2003; 22: Suppl. 45, 167s
Year: 2003
Evaluation of a molecular assay for detection of rifampin and isoniazid resistant
mycobacterium tuberculosis
in strains and clinical samples
Source: Annual Congress 2008 - Genetics, immunology and microbiology of tuberculosis
Year: 2008
The Abbott LCx-MTB assay is more sensitive than culture on Loewenstein Jensen medium for detection of mycobacterium tuberculosis in respiratory specimens and time of sputum conversion in response to antituberculous treatment strongly correlates between
Source: Eur Respir J 2002; 20: Suppl. 38, 580s
Year: 2002
Comparision of line probe assay and conventional methos for detection of mycobacteria other than tuberculosis (MOTT) strains from patients suferring from pulmonary tuberculosis
Source: International Congress 2016 – Non-tuberculous mycobacteria: HIV-TB co-infection and adenosine deaminase (ADA)
Year: 2016
GenoType MTBDR assays for the diagnosis of multidrug-resistant tuberculosis: a meta-analysis
Source: Eur Respir J 2008; 32: 1165-1174
Year: 2008
Detection of M. tuberculosis multi-drug resistance using GenoType® MTBDRplus
Source: Annual Congress 2010 - Tuberculosis drug resistance
Year: 2010
The main clinical problem of increasing resistance of
Mycobacterium tuberculosis
(MT) to first-line anti-TB drugs
Source: Eur Respir J 2005; 26: Suppl. 49, 654s
Year: 2005
Rapid detection of multi-drug-resistant tuberculosis (MDR-TB) in one day using the new molecular-biological test genotype MTBDRÔ
Source: Eur Respir J 2006; 28: Suppl. 50, 290s
Year: 2006
Diagnostic value of PCR-RT for the detection of DNA Mycobacterium tuberculosis complex (MBT) in blood from patient with pulmonary tuberculosis (PT)
Source: Annual Congress 2009 - Diagnostic advances in tuberculosis
Year: 2009
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept